{"id":"W2018650005","doi":"10.1158/1078-0432.ccr-09-1192","title":"Tipifarnib Plus Tamoxifen in Tamoxifen-Resistant Metastatic Breast Cancer: A Negative Phase II and Screening of Potential Therapeutic Markers by Proteomic Analysis","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Tamoxifen; Medicine; Internal medicine; Oncology; Metastatic breast cancer; Breast cancer; Cancer; Metastasis","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009792486,0.000936558,0.001358097,0.0003699173,0.0002969206,0.0005135958,0.0003851501,0.0006815753,0.001770901],"category_scores_gemma":[0.0005385546,0.0003244297,0.0005830184,0.000289063,0.0004726773,0.0003855944,0.0002146969,0.001060232,0.0003088235],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006044582,"about_ca_system_score_gemma":0.0006601961,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004294471,"about_ca_topic_score_gemma":0.001042207,"domain_scores_codex":[0.999729,0.0001131475,0.00001586699,0.00003708622,0.00005286691,0.00005203349],"domain_scores_gemma":[0.9997759,0.0000377909,0.00003761282,0.00002305446,0.00002612549,0.00009944335],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2795484,0.07813829,0.02432561,0.0009030391,0.001371603,0.0007059075,0.0003687862,0.002282127,0.4565141,0.0001790489,0.001913279,0.1537498],"study_design_scores_gemma":[0.1732791,0.6924964,0.076635,0.00005142389,0.001111513,0.001472562,0.0001098115,0.002853599,0.04859804,0.000143108,0.003200823,0.00004858997],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997449,0.001124262,0.0001898676,0.0001040627,0.00001543488,0.0005439465,0.0001748333,0.00001450271,0.0003841172],"genre_scores_gemma":[0.9936312,0.001442211,0.001211257,0.0003082075,0.00007761022,0.001071089,0.001265055,0.000009342728,0.0009840813],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001770901,"threshold_uncertainty_score":0.005924284,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1474246640642809,"score_gpt":0.5366681232496262,"score_spread":0.3892434591853453,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}